---
title: FSD Pharma Files for Phase II Clinical Trials
description: FSD Pharma Files for Phase II Clinical Trials
---

[News ](https://www.yourway.com/news)

# [FSD Pharma Files for Phase II Clinical Trials](https://www.yourway.com/news/fsd-pharma-files-for-phase-ii-clinical-trials)

 Written by [Yourway](https://www.yourway.com/news/author/yourway) | September 15, 2020

FSD Pharma has filed an IND (Investigational New Drug Application) with the FDA for the use of its drug [FSD201](https://www.fsdpharma.com/news/fsd-pharma-announces-phase-2-clinical-trial-ind-filing-with-the-fda-to-treat-patients-with-covid-19/) (ultramicronized palmitoylethanolamide, or ultramicronized PEA) to treat COVID-19. The randomized, controlled, double-blind trial is set to take place at 25-30 hospitals in the U.S. Yourway offers global direct-to-patient trial service 24/7, including during the COVID-19 crisis. As a premium drug product shipments courier, we reduce our client’s timelines with faster response times and agile transport operations.

[View full post](https://www.yourway.com/news/fsd-pharma-files-for-phase-ii-clinical-trials)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Yourway"
  },
  "dateModified" : "2020-09-15T09:00:00.416Z",
  "datePublished" : "2020-09-15T09:00:00Z",
  "headline" : "FSD Pharma Files for Phase II Clinical Trials",
  "image" : {
    "@type" : "ImageObject",
    "height" : 1156,
    "url" : "https://f.hubspotusercontent30.net/hubfs/5402331/images/news_sep/02_iStock-468887383.jpg",
    "width" : 2591
  },
  "mainEntityOfPage" : "https://www.yourway.com/news/fsd-pharma-files-for-phase-ii-clinical-trials",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "News"
  }
}
```